Efficacy of Mesalazine in Children With Moderate to Severe Alopecia Areata: Case Series of 18 Patients

    Analú Vivian, Vânia Oliveira Carvalho, Ana Elisa Kiszewski
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary In this study of 18 children with moderate to severe alopecia areata in Brazil, mesalazine treatment showed varied responses, with 14 patients completing evaluations and two not responding after six months, amidst treatment challenges like relocation and the COVID-19 pandemic.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results